NeuroPace (NPCE) Gross Profit Growth (3y) (2023 - 2026)
NeuroPace (NPCE) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 3.15% |
| 10 | NeuroPace | 519.41 Mn | 465.43 Mn | 18.05 Mn | 20.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.28% |
| Dec 31, 2025 | 32.72% |
| Sep 30, 2025 | 38.52% |
| Jun 30, 2025 | 34.42% |
| Mar 31, 2025 | 28.05% |
| Dec 31, 2024 | 26.09% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | 14.73% |
| Mar 31, 2024 | 16.25% |
| Dec 31, 2023 | 18.12% |
| Sep 30, 2023 | 8.51% |
| Jun 30, 2023 | 30.23% |
| Mar 31, 2023 | 13.70% |